Advances in Lentiviral Technology and Manufacturing Processes

Time: 12:15 pm
day: Day 2 - Track C - Morning


  • Novel lentiviral genomes and associated technology to improve productivity, quality, and enhanced safety
  • Generation of stable, inducible, lentiviral vector producer cell lines (PCL’s) for CAR therapy
  • Development of an improved production process to increase yield, reduce residual contaminants and improve quality